Drug Master File (DMF) is a submission to the Food and Drug Administration (FDA) about the ___________________, processing, packaging, and storing of one or more human drugs.

DMF grade API for formulation comes from ___________________________certified plants

Kidneys reabsorb Glucose via which of the following transporters? (More than 1 Answer)

DAPA HF Trial had _____% pts who were Diabetic

Justoza provides ______% reduction in NTproBNP post 8 month of treatment

Increased Renal Glucose ___________________ May Contribute To Hyperglycemia In Diabetes.

SGLT2 Inhibitors _________________Renal Threshold for Glucose Excretion (RTG)

SGLT-2i offer which of the following benefits. (More than 1 options can be correct)

Dapagliflozin reduces CV Mortality by ___________% as per DAPA-HF

Dapagliflozin causes Hypoglycemia similar to Insulin

In patients with heart failure (NYHA II-IV) with reduced ejection fraction _______________reduces the risk of CV death and hospitalization for heart failure as per DAPA-HF Trial?

Justoza is recommended by _______________as first line therapy in T2DM with CKD & HF

In patients with T2DM with established CVD or multiple CV risk factors, to reduce the risk of hospitalization for Heart Failure dapagliflozin was approved as per which trial?

As per the VA, Dapagliflozin is now indicated as Component of First-line therapy in HFrEF patients as per ____________________________. 

As per Dapa HF Study In HFrEF patients without Diabetes, Dapagliflozin showed _____% reduction in primary composite End point of CV death or Heart Failure Hospitalization

As per Dapa HF Study In HFrEF patients without Diabetes, Dapagliflozin showed _____% reduction in Hospitalization for Heart Failure

Justoza10 mg costing –

Justoza 5mg costing –

Declare-TIMI trial, the largest CVOT with an SGLT2i conducted on  T2DM patients showed that in primary prevention patients, Dapagliflozin reduced the risk of HHF by ___________.

The Primary Composite Outcome of which trial is reduction in Sustained ≥50% eGFR Decline, ESKD, Renal or CV Death?